Back
Phathom Pharmaceuticals Stock Price Chart
Sponsored
Free Report: The Secret Backdoor to OpenAI and ChatGPT
Click here to download it for free with no strings attached.
Buy
52
PHAT
Phathom Pharmaceuticals
Last Price:
7.13
Seasonality Move:
1.92%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
20-cent Gold Stock Has Backing of Major Gold Producers
The time to get in is now BEFORE next drill results are released.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.71 | Buy |
| 20-day SMA: | 7.06 | Buy |
| 50-day SMA: | 8.9 | Sell |
| 200-day SMA: | 9.43 | Sell |
| 8-day EMA: | 6.88 | Buy |
| 20-day EMA: | 7.23 | Sell |
| 50-day EMA: | 8.23 | Sell |
| 200-day EMA: | 10.45 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 45.26 | Sell |
| Chaikin Money Flow: | 312759 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.47 - 8.37) | Sell |
| Bollinger Bands (100): | (7.71 - 11.03) | Sell |
Phathom Pharmaceuticals Technical Analysis
| Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | Mar-27 | Mar-28 | Mar-29 | Mar-30 | Mar-31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 20 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 7.14 while PHAT 8-day simple moving average is 6.71, which is a Buy signal.
- The stock price of PHAT is 7.14 while Phathom Pharmaceuticals 20-day SMA is 7.06, which makes it a Buy.
- Phathom Pharmaceuticals 50-day simple moving average is 8.90 while PHAT share price is 7.14, making it a Sell technically.
- PHAT stock price is 7.14 and Phathom Pharmaceuticals 200-day simple moving average is 9.43, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Buy
52
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a Buy
The current Phathom Pharmaceuticals [PHAT] share price is $7.14. The Score for PHAT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
299.69M
Price in USD:
7.14
Share Volume:
349.55K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
16.07
52-Week Low:
5.84
Buy
52
Phathom Pharmaceuticals (PHAT)
is a Buy
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?
The Phathom Pharmaceuticals stock price is 7.14 USD today. -
Will PHAT stock go up or go down?
Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Phathom Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is not overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 7.14 while PHAT 8-day exponential moving average is 6.88, which is a Buy signal.
- The stock price of PHAT is 7.14 while Phathom Pharmaceuticals 20-day EMA is 7.23, which makes it a Sell.
- Phathom Pharmaceuticals 50-day exponential moving average is 8.23 while PHAT share price is 7.14, making it a Sell technically.
- PHAT stock price is 7.14 and Phathom Pharmaceuticals 200-day simple moving average is 10.45, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.37 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
- PHAT Moving Average Covergence Divergence (MACD) indicator is -0.55, suggesting Phathom Pharmaceuticals is a Sell
- Phathom Pharmaceuticals Relative Strength Index (RSI) is 45.26, which suggest Phathom Pharmaceuticals is oversold
- The Bollinger Bands (25) for Phathom Pharmaceuticals is (6.47 - 8.37), which suggest Phathom Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Phathom Pharmaceuticals is (7.71 - 11.03), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.